首页> 外文期刊>Endocrine. >Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis
【24h】

Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis

机译:泼尼松龙和非甾体抗炎药治疗疗效对亚急性甲状腺炎患者的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Subacute thyroiditis is a transient inflammatory thyroid disease of unknown etiology. The primary goal for treatment is to mitigate inflammation. The aim of this retrospective study was to compare the therapeutic effects of prednisolone and nonsteroidal anti-inflammation drugs in patients with subacute thyroiditis. In this study, 53 consecutive Japanese patients who had been diagnosed with were referred to our hospital for further management. After excluding 11 patients (9 did not need treatment, 2 did not meet the criteria for diagnosis of subacute thyroiditis), the remaining 42 patients were treated either with prednisolone (n = 25) or loxoprofen (n = 17). We compared the time periods required for resolution of clinical symptoms and signs and normalization of thyroid function between the two groups. The mean dose of prednisolone was 15.0 (range, 14-16) mg/day and that of loxoprofen was 180 mg/day. The time period to normalization of thyroid function was comparable between the prednisolone and loxoprofen groups (25, 18-36, vs 32, 21-39 days, p = 0.388). However, the time period for resolution of symptoms was shorter under prednisolone than loxoprofen (7, 7-12 days, vs 21, 14-32 days, p < 0.001). Prednisolone treatment of patients with subacute thyroiditis was superior to nonsteroidal anti-inflammation drugs with regard to resolution of symptoms.
机译:亚急性甲状腺炎是一种未知病因的瞬时炎性甲状腺疾病。治疗的主要目标是减轻炎症。该回顾性研究的目的是比较泼尼松龙和非甾啉抗炎药对亚急性甲状腺炎患者的治疗效果。在这项研究中,已被诊断为我们的医院诊断出来的53名患者进行进一步管理。排除11名患者(9例不需要治疗后,2不符合亚急性甲状腺炎的诊断标准),其余42名患者用泼尼松龙(N = 25)或洛洛芬(N = 17)治疗。我们比较了分辨临床症状所需的时间段和两组之间的甲状腺功能的标志性和标准化。泼尼松龙的平均剂量为15.0(范围,14-16)mg /天,含洛洛芬的含量为180mg /天。甲状腺函数正常化的时间段在泼尼松龙和含洛洛芬基团(25,18-36,Vs 32,21-39天,P = 0.388)之间相当。然而,症状的分辨率的时间段比洛洛芬(7,7-12天,第21,21,32天,P <0.001)短,左右畸形症状短。关于症状的分辨率优于非甾体乳腺炎患者的泼尼松龙治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号